LON:ABCAbcam Share Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Abcam Plc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add GBX 1,287 +17.00 (+1.34 %) (As of 08/7/2020 04:00 PM ET) Add Compare Share Today's Range 1,262Now: GBX 1,287▼ 1,29650-Day Range 1,254MA: GBX 1,343.86▼ 1,43552-Week Range 13.20Now: GBX 1,287▼ 1,584Volume1.38 million shsAverage Volume497,233 shsMarket Capitalization£2.78 billionP/E Ratio61.29Dividend Yield0.94%BetaN/A ProfileAnalyst RatingsAdvanced ChartCompetitorsDividendInsider TradesHeadlinesOptions Chain Abcam plc, together with its subsidiaries, produces and distributes research-grade antibodies and associated protein research tools worldwide. The company primarily offers primary and secondary antibodies; ELISA, matched antibody pairs and multiplex immunoassays; cell and tissue imaging tools; cellular and biochemical assays; proteins and peptides; proteomics tools; agonists, antagonists, activators, and inhibitors; lysates; and multiplex miRNA assays. Its products are used in the areas of cancer, cardiovascular, cell biology, developmental biology, epigenetics, immunology, metabolism, microbiology, neuroscience, signal transduction, and stem cells. The company also sells its products online. Abcam plc was founded in 1998 and is based in Cambridge, the United Kingdom.Read More Beat the Market (BTM) Rank™ 1.1 Analyst's Opinion Consensus RatingAbcam has received a consensus rating of Hold. The company's average rating score is 2.17, and is based on 2 buy ratings, 3 hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of GBX 1,336, Abcam has a potential upside of 3.8% from its current price of GBX 1,287.Amount of Analyst CoverageAbcam has only been the subject of 4 research reports in the past 90 days. Previous Next 1.3 Community Rank Outperform VotesAbcam has received 204 “outperform” votes. (Add your “outperform” vote.)Underperform VotesAbcam has received 568 “underperform” votes. (Add your “underperform” vote.)Community SentimentAbcam has received 73.58% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Abcam and other stocks. Vote “Outperform” if you believe ABC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ABC will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.8 Dividend Strength Dividend YieldAbcam has a dividend yield of 0.94%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthAbcam does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Abcam is 57.14%. This payout ratio is at a healthy, sustainable level, below 75%. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Abcam insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Abcam is 61.29, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 18.05.Price to Earnings Ratio vs. SectorThe P/E ratio of Abcam is 61.29, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 14.72.Price to Book Value per Share RatioAbcam has a P/B Ratio of 6.78. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 1.1Community Rank: 1.3Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.64 out of 5 stars Industry, Sector and Symbol Stock Exchange LON Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolLON:ABC Previous Symbol CUSIPN/A CIKN/A Webwww.abcam.com Phone+44-1223-696000Debt Debt-to-Equity Ratio45.00 Current Ratio1.87 Quick Ratio1.59Price-To-Earnings Trailing P/E Ratio61.29 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales£273.40 million Price / Sales10.18 Cash FlowGBX 92.64 per share Price / Cash Flow13.89 Book ValueGBX 189.90 per share Price / Book6.78Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees1,100 Outstanding Shares216,172,992Market Cap£2.78 billion Next Earnings Date9/14/2020 (Estimated) OptionableOptionable GBX 1,287 +17.00 (+1.34 %) (As of 08/7/2020 04:00 PM ET) 30 days | 90 days | 365 days | Advanced Chart Receive ABC News and Ratings via Email Sign-up to receive the latest news and ratings for ABC and its competitors with MarketBeat's FREE daily newsletter. Abcam (LON:ABC) Frequently Asked Questions How has Abcam's stock been impacted by COVID-19 (Coronavirus)? Abcam's stock was trading at GBX 1,140 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ABC stock has increased by 12.9% and is now trading at GBX 1,287. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Abcam? 6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Abcam in the last year. There are currently 1 sell rating, 3 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Abcam. When is Abcam's next earnings date? Abcam is scheduled to release its next quarterly earnings announcement on Monday, September 14th 2020. View our earnings forecast for Abcam. How often does Abcam pay dividends? What is the dividend yield for Abcam? Abcam declared a dividend on Monday, March 9th. Stockholders of record on Thursday, March 19th will be given a dividend of GBX 3.55 per share on Friday, April 17th. This represents a yield of 0.31%. The ex-dividend date is Thursday, March 19th. The official announcement can be accessed at this link. View Abcam's dividend history. What price target have analysts set for ABC? 6 brokers have issued 1 year price objectives for Abcam's stock. Their forecasts range from GBX 1,220 to GBX 1,450. On average, they anticipate Abcam's share price to reach GBX 1,336 in the next year. This suggests a possible upside of 3.8% from the stock's current price. View analysts' price targets for Abcam. Has Abcam been receiving favorable news coverage? Press coverage about ABC stock has trended very positive recently, according to InfoTrie Sentiment. The research group identifies positive and negative media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Abcam earned a media sentiment score of 4.0 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the next few days. View the latest news about Abcam. Who are some of Abcam's key competitors? Some companies that are related to Abcam include Vir Biotechnology (VIR), MORGAN STANLEY Morgan Stanley Capital Protected Notes Based on S&P 500 (MOR), MorphoSys (MOR), MorphoSys (MOR), BTG (BTG), Cronos Group (CRON), Genus (GNS), Kodiak Sciences (KOD), Viela Bio (VIE), Mesoblast (MSB), Polynovo (PNV), NGM Biopharmaceuticals (NGM), Concordia International (CXR), Clinuvel Pharmaceuticals (CUV) and Altimmune (ALT). View all competitors. What other stocks do shareholders of Abcam own? Based on aggregate information from My MarketBeat watchlists, some companies that other Abcam investors own include Hawkins (HWKN), CA (CA), Endologix (ELGX), BlackRock (BLK), Aegean Marine Petroleum Network (ANW), Athabasca Oil (ATH), Chipotle Mexican Grill (CMG), HSBC (HSBA), Centrica (CNA) and Marks and Spencer Group (MKS). Who are Abcam's key executives? Abcam's management team includes the following people: Mr. Alan Thomas Hirzel BS, MS, MBA, CEO & Exec. Director (Age 51)Dr. Jonathan Simon Milner, Co-Founder & Non-Exec. Deputy Chairman (Age 54)Mr. Gavin Hilary James Wood BA (Hons), ACA, CFO & Exec. Director (Age 49)James Staveley, VP of Investor RelationsMr. Nick Skinner, Sr. VP of HR What is Abcam's stock symbol? Abcam trades on the London Stock Exchange (LON) under the ticker symbol "ABC." How do I buy shares of Abcam? Shares of ABC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Abcam's stock price today? One share of ABC stock can currently be purchased for approximately GBX 1,287. How big of a company is Abcam? Abcam has a market capitalization of £2.78 billion and generates £273.40 million in revenue each year. Abcam employs 1,100 workers across the globe. What is Abcam's official website? The official website for Abcam is www.abcam.com. How can I contact Abcam? Abcam's mailing address is 330 Cambridge Science Park, CAMBRIDGE, CB4 0FL, United Kingdom. The company can be reached via phone at +44-1223-696000. This page was last updated on 8/8/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
